No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

King Faisal Specialist Hospital & Research Center

Status: Completed

Conditions: Differentiated Thyroid Cancer

Treatments: Other: No additional drugs(control Group)

Study type: Observational

Funder types: Other

Identifiers

NCT07115810

RAC#2110031

Details and patient eligibility

About

The goal of this observational study is to compare the clinical outcomes, molecular features, and immune profiles of patients with synchronous and metachronous distant metastases in Saudi cohort with well characterized differentiated thyroid cancer. The main question it aims to answer is whether timing of metastasis is associated with distinct prognostic or biological behavior in differentiated thyroid cancer from a large Middle Eastern cohort

Enrollment: 178 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Synchronous or metachronous distant metastases

Exclusion criteria

• Not DTC
• No distant metastases

Trial design

178 participants in 1 patient group

Metastatic DTC

Treatment:

Other: No additional drugs(control Group)